Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003

被引:38
作者
Deambrosis, Paola
Saramin, Cristina
Terrazzani, Gianni
Scaldaferri, Luca
Debetto, Patrizia
Giusti, Pietro
Chinellato, Alessandro
机构
[1] Univ Padua, Dept Pharmacol & Anesthesiol, I-35131 Padua, Italy
[2] Local Hlth Author, ULSS 9, Pharmaceut Serv, Treviso, Italy
[3] Local Hlth Author, ULSS 9, Antidiabet Unit, Treviso, Italy
关键词
adherence to therapy (ATI); DDD; drug utilization; persistence with therapy; statins;
D O I
10.1007/s00228-006-0239-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives The prescription pattern of statins in the Local Health Unit (LHU) of Treviso (northern Italy) over a 10-year period was evaluated, with the aim of evaluating the persistence with and adherence to therapy. Methods Data on 21,393 subjects who received at least one prescription for statins during the period between January 1, 1994 and December 31, 2003 were retrieved from the LHU database in order to track the pharmacological history of individual patients. The data included age, sex, drug formulation, strength, number of drug packages prescribed, and prescription date. The adopted indicators for drug utilization included the Defined Daily Dose (DDD), the Received Daily Dose (RDD), and a surrogated Prescribed Daily Dose (sPDD), extrapolated from available prescription data. An Adherence to Therapy Index (ATI) was calculated from the ratio between the amount of drug actually prescribed and the amount of sPDD. Based on the ATI, patients were grouped into non-adherent, poor-adherent, and good-adherent groups. The distribution of adherence level among patient-age classes and statin-prescribed patients in primary or secondary prevention was evaluated. Results All drug-utilization indicators showed an increase in statin use over the study period in terms of both the number of prescribed patients and the sPDD. Persistence with and adherence to therapy remained low, with a 50% discontinuation rate in the first year, and persistent patients did not follow the therapy regularly. Patients in secondary prevention were the most adherent to their drug regimen, although only 41% of these had a good compliance. Conclusions Our findings suggest an increase in statin use which is, however, accompanied by poor patient persistence with and adherence to statin therapy.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 21 条
[1]   Persistence of use of lipid-lowering medications - A cross-national study [J].
Avorn, J ;
Monette, J ;
Lacour, A ;
Bohn, RL ;
Monane, M ;
Mogun, H ;
LeLorier, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18) :1458-1462
[2]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[3]   Retrospective analysis of opioid prescriptions in cancer patients in a northern Italian Region [J].
Chinellato, Alessandro ;
Terrazzani, Gianni ;
Debetto, Patrizia ;
Zambon, Paola ;
Guzzinati, Stefano ;
Walley, Tom ;
Giusti, Pietro .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (01) :130-133
[4]  
DEAMBROSIS P, 2005, PHARMACOECONOMICS, V7, P187
[5]  
Eriksson M, 1998, J INTERN MED, V243, P373
[6]  
Genest J, 2003, CAN MED ASSOC J, V169, P921
[7]   Cholesterol lowering with statin drugs, risk of stroke, and total mortality - An overview of randomized trials [J].
Hebert, PR ;
Gaziano, JM ;
Chan, KS ;
Hennekens, CH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 278 (04) :313-321
[8]   Initial phase of chronic medication use; patients' reasons for discontinuation [J].
Hugtenburg, JG ;
Blom, ATG ;
Kisoensingh, SU .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (03) :352-354
[9]   Lack of adherence to lipid-lowering drug treatment. A comparison of utilization patterns in defined populations in Funen, Denmark and Bologna, Italy [J].
Larsen, J ;
Vaccheri, A ;
Andersen, M ;
Montanaro, N ;
Bergman, U .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 49 (05) :463-471
[10]  
*MIN SAL, 2003, US FARM IT RAPP NAZ, P82